# Marko A. Mychaskiw

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marko-a-mychaskiw/

## Facts

| Field | Value |
| --- | --- |
| Citations | 666 |
| Field | Schizophrenia research and treatment |
| h-index | 14 |
| i10-index | 17 |
| Last Known Institution | Health Economics and Outcomes Research (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5111458756 |
| Works | 46 |

## Researcher papers

- [Association of subjective anxiety, depression, and sleep disturbance with quality‐of‐life ratings in adults with epilepsy](https://scholariq.org/papers/association-of-subjective-anxiety-depression-and-sleep-disturbance-with-quality/)
- [Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature](https://scholariq.org/papers/prevalence-of-pulmonary-arterial-hypertension-in-patients-with-connective-tissue/)
- [Cost-effectiveness of Treating Ocular Hypertension](https://scholariq.org/papers/cost-effectiveness-of-treating-ocular-hypertension/)
- [Accounting for Restart Rates in Evaluating Persistence with Ocular Hypotensives](https://scholariq.org/papers/accounting-for-restart-rates-in-evaluating-persistence-with-ocular-hypotensives/)
- [Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study](https://scholariq.org/papers/medication-adherence-and-utilization-in-patients-with-schizophrenia-or-bipolar/)
- [Adherence, Persistence of Use, and Costs Associated With Second-Generation Antipsychotics for Bipolar Disorder](https://scholariq.org/papers/adherence-persistence-of-use-and-costs-associated-with-second-generation/)
- [Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study](https://scholariq.org/papers/changes-in-healthcare-utilization-and-costs-associated-with-sildenafil-therapy/)
- [Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians](https://scholariq.org/papers/management-of-schizophrenia-with-long-acting-injectable-antipsychotic/)
- [Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective](https://scholariq.org/papers/cost-effectiveness-of-pregabalin-versus-venlafaxine-in-the-treatment-of/)
- [Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database](https://scholariq.org/papers/early-versus-late-administration-of-long-acting-injectable-antipsychotic-agents/)
- [Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease](https://scholariq.org/papers/incremental-health-care-resource-utilization-and-expenditures-associated-with/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Bipolar Disorder and Treatment](https://scholariq.org/topics/bipolar-disorder-and-treatment/)

## Researcher university

- [Health Economics and Outcomes Research (United Kingdom)](https://scholariq.org/institutions/health-economics-and-outcomes-research-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.